MICROBOT MEDICAL INC. : Regulation FD Disclosure (form 8-K)

Item 7.01 Regulation FD Disclosure.

On January 21, 2021, Microbot Medical Inc. (the "Company") issued a press release announcing that the Company continues to enhance its thought leadership capabilities with the addition of several new Scientific Advisory Board (SAB) members:

  ? Stephen B. Solomon, MD, a board-certified radiologist with clinical expertise
    in Interventional Radiology with a focus in Tumor Ablation;

  ? Ajay K. Wakhloo, MD PhD FAHA, an internationally recognized expert in acute
    stroke therapy and the isolation of intracranial aneurysms and arteriovenous
    malformations;

  ? Gal Yaniv, MD, PhD, an endovascular neurosurgeon and leading authority on
    Artificial Intelligence;

  ? Dmitry J. Rabkin, MD, PhD, FSIR, a vascular and Interventional Radiology
    Specialist; and

  ? Ziv Neeman, MD, a vascular and interventional radiology clinician and
    researcher with a wide array of expertise, particularly in the field of
    navigation systems for minimally invasive image-guided interventional
    procedures.

The press release furnished as Exhibit 99.1 to this Current Report on Form 8-K are incorporated herein by reference. The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. This report will not be deemed an admission as to the materiality of any information herein (including Exhibit 99.1).

© Edgar Online, source Glimpses